On September 24, 2007, New Brunswick Scientific Co., Inc. ("NBS") and Eppendorf Group ("Eppendorf") announced the completion of a merger transaction in which Eppendorf has acquired NBS for approximately $110 million, or $11.50 per share, in an all-cash transaction. As a result of the merger, NBS has ceased to be a publicly traded company and, effective September 25, 2007, its shares will no longer be listed and no further trading in NBS stock on the NASDAQ Global Market will occur.
Eppendorf has appointed American Stock Transfer & Trust Company as paying agent, and, will promptly mail a letter of transmittal and instructions to all NBS shareholders of record. The letter of transmittal and instructions will contain information on how to surrender stock certificates representing shares of NBS common stock in exchange for $11.50 per share, without interest. NBS' shareholders of record should wait until they receive the letter of transmittal before surrendering their stock certificates. Shareholders who hold shares through a bank or broker will not have to take any action to have their shares exchanged for the merger consideration as such exchanges will be handled by the bank or broker.
About Eppendorf
Eppendorf is a global leader in laboratory equipment and associated consumables. Eppendorf products include liquid handling and centrifugation equipment products including related consumables as well as instruments and systems for PCR, cell technology and micro arrays that are used by researchers in life science, drug discovery, clinical, environmental and industrial laboratories. Founded in 1945, Eppendorf, a privately held company headquartered in Hamburg, Germany, has revenues of more than $400 million, and employs approximately 2,000 people in over 20 countries.
News releases and other information on Eppendorf are available on the Internet at: http://www.eppendorf.com
